With its personalized vaccine, BioNTech is a pioneer in the battle against cancer. To enable the active pharmaceutical ingredient (API) to be produced faster and in large quantities, the company has installed an entirely paperless manufacturing system featuring Simatic IT eBR and Preactor.
Source : https://new.siemens.com/global/en/company/stories/industry/biontech-targeting-cancer.html
Date : August 28, 2019 at 07:29PM
Tag(s) : Acteurs,Software,#eSANTE ENG
